Mucrolidin is primarily used for its anti-inflammatory and immunomodulatory properties. It has shown potential in research settings for managing chronic inflammatory conditions, particularly those involving mucosal tissues. The compound is investigated for its ability to reduce mucus hypersecretion and support tissue repair in respiratory disorders. It may also play a role in regulating cytokine production, making it relevant in studies on autoimmune responses and allergic reactions. Due to its biological activity, Mucrolidin is utilized in preclinical studies to explore new therapeutic pathways in diseases like asthma, chronic obstructive pulmonary disease (COPD), and certain gastrointestinal inflammations. Its application remains mostly experimental, with ongoing research to determine clinical viability.